| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/10/2002 | CA2425285A1 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis |
| 05/10/2002 | CA2425067A1 Aza-and polyaza-naphthalenyl ketones useful as hiv integrase inhibitors |
| 05/10/2002 | CA2395324A1 Expression potentiator for protein synthesis regulatory gene |
| 05/09/2002 | WO2002036153A1 Expression potentiator for protein synthesis regulatory gene |
| 05/09/2002 | US20020056146 Expression vector for use in generation of trangenic animals; for use in animal modeling of disease |
| 05/09/2002 | US20020055643 Tubulin binding ligands and corresponding prodrug constructs |
| 05/09/2002 | US20020055636 Pyrroloquinolones as antiviral agents |
| 05/09/2002 | US20020055632 Such as (3R,5S)-1-pyrimidin-2-yl-5-(2,4,5-trifluoro-benzyloxymethyl)-pyrrolidine-3 -thiol trifluoro-acetate useful as inhibitors of metalloproteases for treating diseases associated with vasoconstriction |
| 05/09/2002 | US20020055616 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 05/09/2002 | US20020055615 Functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathology and physiology |
| 05/09/2002 | US20020055614 Immune reactivity to her-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated |
| 05/09/2002 | US20020055543 Inhibit phosphodiesterase type IV or inhibit the production of tumor necrosis factor; useful in treating diseases including asthma, arthritis, and sepsis. |
| 05/09/2002 | US20020055526 Modulators of SKCa, IKCa and BKCa channels. |
| 05/09/2002 | US20020055523 Inhibiting a PTPase treating type 1 and 2 diabetes, insulin resistance and pathological obesity |
| 05/09/2002 | US20020055519 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists |
| 05/09/2002 | US20020055516 Nitrogen-containing heterocyclic compounds and medicaments containing the compounds |
| 05/09/2002 | US20020055515 Contacting stimulated cells with a candidate compound which is an inhibitor of ATP binding to a P2Y- purinoceptor; and assaying said cells for release of one or more mediators. |
| 05/09/2002 | US20020055507 Ureas and thioureas inhibit production of cytokines |
| 05/09/2002 | US20020055489 Interleukin-12 inducer and medical composition |
| 05/09/2002 | US20020055484 Methods for modulating the axonal outgrowth of central nervous system neurons |
| 05/09/2002 | US20020055480 SOX-9 gene and protein and use in the regeneration of bone or cartilage |
| 05/09/2002 | US20020055469 Anticoagulants |
| 05/09/2002 | US20020055163 Amino acid sequences of peptides that are encoded by genes within the human genome, the protease peptides; useful in the development of human therapeutics and diagnostic formulations |
| 05/09/2002 | US20020055142 Major intrinsic protein (MIP)-like polynucleotides, polypeptides, and antibodies |
| 05/09/2002 | US20020055122 Administering to the recipient mammal for promoting acceptance of graft, an inhibitor of the CD40/ ligand- CD40 costimulatory interaction; introducing into the recipient mammal, hematopoietic stem cells and implanting the graft |
| 05/09/2002 | US20020054926 Administering tobacco extract, Yerbamate extract, and extract of chewing gum and lozenges for increasing levels of norepinephrine, dopamine, and serotonin to treat psychological disorders and aid in smoking cessation |
| 05/09/2002 | US20020054922 Cosmetic composition and method |
| 05/09/2002 | US20020054916 Comprising ceruloplasmin and a serum-derived composition (SDF) having a low molecular weight, electrically charged at acidic pH and having absorption at 280 mn, capable of inducing terminal cell differentiation of leukemic cells |
| 05/09/2002 | US20020054907 Multiparticulate modified release composition |
| 05/09/2002 | US20020054904 Stable pergolide mesylate and process for making same |
| 05/09/2002 | US20020054899 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 05/09/2002 | US20020054881 Variants can be used in specific immunotherapy of allergic pathologies caused by dust mites |
| 05/09/2002 | US20020054878 Anti-IgE antibodies |
| 05/08/2002 | EP1203958A2 High-throughput screening method |
| 05/08/2002 | EP1203819A2 Anti-inflammatory vectors |
| 05/08/2002 | EP1203767A1 Heterocyclic-substituted alkylamide acat inhibitors |
| 05/08/2002 | EP1203239A2 Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease |
| 05/08/2002 | EP1203233A1 Method for identifying modulating compounds of neurotransmitters |
| 05/08/2002 | EP1203095A2 Screen for nitric oxide synthase modulators |
| 05/08/2002 | EP1203088A2 Conditionally controlled, attenuated hiv vaccine |
| 05/08/2002 | EP1203081A2 Human intracellular signaling molecules |
| 05/08/2002 | EP1203016A2 Proteases and protease inhibitors |
| 05/08/2002 | EP1203010A1 Antisense modulation of fadd expression |
| 05/08/2002 | EP1203009A1 Antisense modulation of jun n-terminal kinase kinase-1 expression |
| 05/08/2002 | EP1203008A1 Nucleic acid ligands to cd40ligand |
| 05/08/2002 | EP1203005A2 25 human secreted proteins |
| 05/08/2002 | EP1203004A1 HIGH AFFINITY TGF$g(g) NUCLEIC ACID LIGANDS AND INHIBITORS |
| 05/08/2002 | EP1202994A1 New compounds |
| 05/08/2002 | EP1202993A2 Phenanthroline-7-one derivatives and their therapeutic uses |
| 05/08/2002 | EP1202991A1 Pharmaceutical compositions containing thiazolidinedione derivatives and process for their preparation |
| 05/08/2002 | EP1202988A2 Novel integrin receptor antagonists |
| 05/08/2002 | EP1202986A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 05/08/2002 | EP1202984A1 Novel diphenyl-piperidine derivate |
| 05/08/2002 | EP1202980A1 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands |
| 05/08/2002 | EP1202976A1 Pyrazinones, compositions containing such compounds |
| 05/08/2002 | EP1202975A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| 05/08/2002 | EP1202974A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/08/2002 | EP1202970A1 Cyclic amine derivatives for the treatment of neurological diseases |
| 05/08/2002 | EP1202968A2 Antibacterial agents |
| 05/08/2002 | EP1202967A2 Sulfuric acid mono-[3-((1-(2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl)-hydroxy-methyl)-2-methoxy-phenyl]ester |
| 05/08/2002 | EP1202966A1 Piperidine alcohols |
| 05/08/2002 | EP1202965A1 Indole derivatives, processes for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 05/08/2002 | EP1202964A1 Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands |
| 05/08/2002 | EP1202963A1 Spla2 inhibitors |
| 05/08/2002 | EP1202961A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 05/08/2002 | EP1202959A1 Aminobenzophenones as inhibitors of il-1-beta and tnf-alpha |
| 05/08/2002 | EP1202955A2 1,4-substituted 4,4-diaryl cyclohexanes |
| 05/08/2002 | EP1202954A1 Novel aminobenzophenones |
| 05/08/2002 | EP1202755A1 Cartilage or bone matrix as a nucleic acid delivery vehicle |
| 05/08/2002 | EP1202749A2 Enzyme catalyzed anti-infective therapeutic agents |
| 05/08/2002 | EP1202747A1 Sustained release drug dispersion delivery device |
| 05/08/2002 | EP1202746A1 Nsaid and efgr kinase inhibitor containing composition for the treatment or inhibition of colonic polyps and colorectal cancer |
| 05/08/2002 | EP1202744A2 PRODUCTION OF rhPBGD AND NEW THERAPEUTIC METHODS FOR TREATING PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP) AND OTHER PORPHYRIC DISEASES |
| 05/08/2002 | EP1202738A1 Dihydropyrazine derivatives as npy antagonists |
| 05/08/2002 | EP1202737A2 Antiviral therapy use of p-glycoprotein modulators |
| 05/08/2002 | EP1202736A1 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 05/08/2002 | EP1202733A1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 05/08/2002 | EP1202731A2 Method for treating chronic pain using mek inhibitors |
| 05/08/2002 | EP1202729A1 Phosphate transport inhibitors |
| 05/08/2002 | EP1202728A2 Peroxovanadium compounds as protein tyrosine phosphatase (ptp) inhibitors: their inhibitory effects on angiogenesis, restenosis and the production of endothelins, and their stimulating effects on the immune response |
| 05/08/2002 | EP1202726A2 Method for treating chronic pain using mek inhibitors |
| 05/08/2002 | EP1202724A2 Method for treating chronic pain using mek inhibitors |
| 05/08/2002 | EP1202723A2 Use of anti-muscarinic agents for treating skin disorders |
| 05/08/2002 | EP1202718A2 Substituted guanidines for the treatment of cancer and pain |
| 05/08/2002 | EP1202717A2 Naaladase inhibitors in anxiety and memory disorders |
| 05/08/2002 | EP1202628A1 Novel hypoxanthine and thiohypoxanthine compounds |
| 05/08/2002 | EP1202626A1 Alpha-hydroxy-gamma-[[(carbocyclic-or heterocyclic-substituted)amino]carbonyl]alkanamide derivatives and uses thereof |
| 05/08/2002 | EP1202620A1 Anti-inflammatory therapy for inflammatory mediated infection |
| 05/08/2002 | EP1024823B1 Prevention and treatment of adhesion formation |
| 05/08/2002 | EP0998299A4 ISOLATED PEPTIDES WHICH COMPLEX WITH HLA-Cw*16 MOLECULES, AND USES THEREOF |
| 05/08/2002 | EP0923585B1 Phosphinate based inhibitors of matrix metalloproteases |
| 05/08/2002 | EP0804464B1 Aromatic heterocyclic derivatives as enzyme inhibitors |
| 05/08/2002 | EP0726766B1 Novel pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound |
| 05/08/2002 | EP0708653B1 Assay and reagents for identifying anti-proliferative agents |
| 05/08/2002 | DE10054482A1 Heteroarylacryloylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical compositions containing them |
| 05/08/2002 | DE10054481A1 Acylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate Acylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical compositions containing them |
| 05/08/2002 | DE10053870A1 Procollagen (III)-Propeptide und verwandte Substanzen zur Behandlung von fibrotischen Erkrankungen Procollagen (III) propeptides and related substances for the treatment of fibrotic diseases |
| 05/08/2002 | DE10053813A1 Neue Verwendung von Sulfonamiden New use of sulfonamides |
| 05/08/2002 | CN1348498A Novel Nucleic acid transferring agents, compsoitions containing them and uses |
| 05/08/2002 | CN1348465A Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains |